sglt2 inhibitors and glp-1 receptor agonists agonists: a sound combination GLP-1 Receptor Agonist Therapy With

Most studies have reported that GLP-1RAs have renoprotective effects

Many of the changes in lipid profiles related to obesity overlap with diabetic dyslipidemia including increased triglycerides, increased very-low-density lipoprotein (VLDL), increased small density LDL-C, and decreased HDL-C [18]

GLP-1 receptor agonists and renal outcomes in patients with diabetes mellitus type 2 and diabetic kidney disease: state of the art

Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study

No funding was received for this research

Second, determining the ideal timing and priority to intensify therapy is also urgently required, since present evidence are not enough to cover this evidence gap